G435-0025 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-1-{2-phenylpyrazolo[1,5-a]pyrazin-4-yl}piperidine-4-carboxamide

G435-0025 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-1-{2-phenylpyrazolo[1,5-a]pyrazin-4-yl}piperidine-4-carboxamide
G435-0025 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-1-{2-phenylpyrazolo[1,5-a]pyrazin-4-yl}piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G435-0025
N-[(2H-1,3-benzodioxol-5-yl)methyl]-1-{2-phenylpyrazolo[1,5-a]pyrazin-4-yl}piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G435-0025

Molecular Formula

C26H25N5O3 (C26 H25 N5 O3)

Compound Name

N-[(2H-1,3-benzodioxol-5-yl)methyl]-1-{2-phenylpyrazolo[1,5-a]pyrazin-4-yl}piperidine-4-carboxamide

IUPAC name

N-[(2H-13-benzodioxol-5-yl)methyl]-1-{2-phenylpyrazolo[15-a]pyrazin-4-yl}piperidine-4-carboxamide

SMILES

O=C(C(CC1)CCN1c(c1c2)nccn1nc2-c1ccccc1)NCc(cc1)cc2c1OCO2

InChI

InChI=1S/C26H25N5O3/c32-26(28-16-18-6-7-23-24(14-18)34-17-33-23)20-8-11-30(12-9-20)25-22-15-21(19-4-2-1-3-5-19)29-31(22)13-10-27-25/h1-7,10,13-15,20H,8-9,11-12,16-17H2,(H,28,32)

InChI Key

OREAASFYACRONO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27142086

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

455.52

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.554

Distribution Coefficient, logD

3.552

Water Solubility, LogSw

-3.55

Polar Surface Area

64.803

Acid Dissociation Constant (pKa)

14.07

Base Dissociation Constant (pKb)

5.04

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.90

G435-0025 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with G435-0025 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G435-0025?
Check Price and Availability of G435-0025, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G435-0025 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G435-0025
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G435-0025
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G435-0025 available by request